Cyclobenzaprine
Brand names,
Cyclobenzaprine
Analogs
Cyclobenzaprine
Brand Names Mixture
Cyclobenzaprine
Chemical_Formula
C20H21N
Cyclobenzaprine
RX_link
http://www.rxlist.com/cgi/generic/cyclobnz.htm
Cyclobenzaprine
fda sheet
Cyclobenzaprine
msds (material safety sheet)
Cyclobenzaprine
Synthesis Reference
Villani et al.; J. Org. Med. Pharm. Chem. 5, 373 (1962)
Cyclobenzaprine
Molecular Weight
275.387 g/mol
Cyclobenzaprine
Melting Point
216-218 oC (HCl salt)
Cyclobenzaprine
H2O Solubility
Freely Soluble
Cyclobenzaprine
State
Solid
Cyclobenzaprine
LogP
4.974
Cyclobenzaprine
Dosage Forms
Tablet (5 mg, 10 mg)
Cyclobenzaprine
Indication
For use as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.
Cyclobenzaprine
Pharmacology
Cyclobenzaprine, closely related to the antidepressant amitriptyline, is used as a skeletal muscle relaxant to reduce pain and tenderness and improve mobility. Unlike dantrolene, cyclobenzaprine cannot be used to treat muscle spasm secondary to cerebral or spinal cord disease.
Cyclobenzaprine
Absorption
Slowly but well absorbed after oral administration
Cyclobenzaprine
side effects and Toxicity
Oral mouse and rat LD50 are 338 mg/kg and 425 mg/kg respectively. Signs of overdose include agitation, coma, confusion, congestive heart failure, convulsions, dilated pupils, disturbed concentration, drowsiness, hallucinations, high or low temperature, increased heartbeats, irregular heart rhythms, muscle stiffness, overactive reflexes, severe low blood pressure, stupor, and vomiting.
Cyclobenzaprine
Patient Information
FLEXERIL, especially when used with alcohol or other CNS depressants, may impair mental and/or
physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor
vehicle. In the elderly, the frequency and severity of adverse events associated with the use of cyclobenzaprine,
with or without concomitant medications, is increased. In elderly patients, FLEXERIL should be initiated with a 5 mg
dose and titrated slowly upward.
Cyclobenzaprine
Organisms Affected
Humans and other mammals